A Trial to Learn How BAY1834845 and BAY1830839 Affect Inflammation When Taken by Mouth Twice a Day for 7 Days in a Row in Healthy Male Participants

Clinical trial NCT05003089 · COMPLETED

Trial details

NCT number: NCT05003089
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Immune Mediated Inflammatory Diseases

Start date: 2021-06-28
Primary completion: 2021-12-16
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.